Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2003;41:1111-1117
Published online before print April 14, 2003, doi: 10.1161/01.HYP.0000068200.09187.1E
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
41/5/1111    most recent
01.HYP.0000068200.09187.1Ev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fegan, P. G.
Right arrow Articles by Shore, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fegan, P. G.
Right arrow Articles by Shore, A. C.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Blood Pressure Medicines
*Diabetes
*High Blood Pressure
Related Collections
Right arrow Other hypertension
Right arrow Hypertension - basic studies
Right arrow Type 2 diabetes
Right arrow Clinical Studies

(Hypertension. 2003;41:1111.)
© 2003 American Heart Association, Inc.


Scientific Contributions

Capillary Pressure in Subjects With Type 2 Diabetes and Hypertension and the Effect of Antihypertensive Therapy

P. Gerard Fegan; John E. Tooke; Kim M. Gooding; Jayne M. Tullett; Kenneth M. MacLeod; Angela C. Shore

From Clinical Microvascular Research, Peninsula Medical School, Exeter, United Kingdom.

Correspondence to Professor A.C. Shore, Clinical Microvascular Research, Institute of Biomedical and Clinical Science, Peninsula Medical School, Barrack Road, Exeter EX2 5AX, UK. E-mail Angela.shore{at}pms.ac.uk

Raised capillary pressure has been implicated in the formation of diabetic microangiopathy in type I diabetes, in which it is elevated in those with the earliest signs of diabetic kidney disease but remains normal in those without complications. In subjects with type 2 diabetes without complications, capillary pressure is normal, although alterations in the pressure waveforms suggested enhanced wave reflections. The nature of skin capillary pressure in subjects with type 2 diabetes and hypertension remains to be elucidated, as does the effect of blood pressure–lowering therapy on capillary pressure in these subjects. Three studies were performed in well-matched groups. First, capillary pressure was elevated in hypertensive subjects with type 2 diabetes compared with normotensive subjects with type 2 diabetes (20.2 [17.4 to 22.7] mm Hg versus 17.7 [16.1 to 18.9] mm Hg, respectively, P<0.03, Mann-Whitney U test). Second, no significant difference was detected between hypertensive subjects with type 2 diabetes and hypertensive subjects without type 2 diabetes (19.4 [15.8 to 21.3] mm Hg versus 17.2 [15.1 to 19.8] mm Hg, respectively, P=0.5, Mann-Whitney U test). Finally, patients with type 2 diabetes were recruited to a case-control study. Seven subjects received blood pressure–lowering therapy and 8 did not. Therapy reduced capillary pressure from 18.2 [15.8 to 20.1] mm Hg to 15.9 [15.4 to 17.0] mm Hg (P=0.024 ANOVA), in contrast to the lack of effect of time alone. Mean arterial pressure was reduced from 110 [102 to 115] mm Hg to 105 [101 to 111] mm Hg (P=0.006, ANOVA). These findings provide a plausible mechanism by which reducing arterial hypertension may reduce the risk of microangiopathy in type 2 diabetes.


Key Words: antihypertensive therapy • capillaries • diabetes mellitus • microcirculation • vasculature




This article has been cited by other articles:


Home page
HypertensionHome page
M. A. James, J. Tullett, A. G. Hemsley, and A. C. Shore
Effects of Aging and Hypertension on the Microcirculation
Hypertension, May 1, 2006; 47(5): 968 - 974.
[Abstract] [Full Text] [PDF]


Home page
Diabetes and Vascular Disease ResearchHome page
A. F. Kernohan, A. Spiers, N. Sattar, C. Hillier, S. J Cleland, M. Small, M.-A. Lumsden, J. M. Connell, and J. R Petrie
Effects of low-dose continuous combined HRT on vascular function in women with type 2 diabetes
Diabetes and Vascular Disease Research, October 1, 2004; 1(2): 82 - 88.
[Abstract] [PDF]